198 related articles for article (PubMed ID: 3117952)
41. A kinetic model of the circulatory regulation of tissue plasminogen activator during orthotopic liver transplantation.
Crookston KP; Marsh CL; Chandler WL
Blood Coagul Fibrinolysis; 2000 Jan; 11(1):79-88. PubMed ID: 10691102
[TBL] [Abstract][Full Text] [Related]
42. International Society on Thrombosis and Haemostasis score for overt disseminated intravascular coagulation predicts organ dysfunction and fatality in sepsis patients.
Voves C; Wuillemin WA; Zeerleder S
Blood Coagul Fibrinolysis; 2006 Sep; 17(6):445-51. PubMed ID: 16905947
[TBL] [Abstract][Full Text] [Related]
43. Behaviour of protein C inhibitor in intravascular coagulation and liver disease.
Francis RB; Thomas W
Thromb Haemost; 1984 Aug; 52(1):71-4. PubMed ID: 6548588
[TBL] [Abstract][Full Text] [Related]
44. Effect of the administration of recombinant hirudin and/or tissue-plasminogen activator (t-PA) on endotoxin-induced disseminated intravascular coagulation model in rabbits.
Muñoz MC; Montes R; Hermida J; Orbe J; Páramo JA; Rocha E
Br J Haematol; 1999 Apr; 105(1):117-21. PubMed ID: 10233373
[TBL] [Abstract][Full Text] [Related]
45. A dynamic test to investigate potential tissue plasminogen activator activity. Comparison of deamino-8-D-argininevasopressin with venous occlusion in normal subjects and patients.
Sultan Y; Harris A; Strauch G; Venot A; De Lauture D
J Lab Clin Med; 1988 Jun; 111(6):645-53. PubMed ID: 3131470
[TBL] [Abstract][Full Text] [Related]
46. Relation of depressive mood to plasminogen activator inhibitor, tissue plasminogen activator, and fibrinogen levels in patients with versus without coronary heart disease.
Lahlou-Laforet K; Alhenc-Gelas M; Pornin M; Bydlowski S; Seigneur E; Benetos A; Kierzin JM; Scarabin PY; Ducimetiere P; Aiach M; Guize L; Consoli SM
Am J Cardiol; 2006 May; 97(9):1287-91. PubMed ID: 16635597
[TBL] [Abstract][Full Text] [Related]
47. Fibrinolytic response and fibrin fragment D-dimer levels in patients with deep vein thrombosis.
Declerck PJ; Mombaerts P; Holvoet P; De Mol M; Collen D
Thromb Haemost; 1987 Dec; 58(4):1024-9. PubMed ID: 3127914
[TBL] [Abstract][Full Text] [Related]
48. [Classification and treatment of DIC].
Asakura H; Saito M
Rinsho Ketsueki; 1995 Apr; 36(4):314-9. PubMed ID: 7783336
[TBL] [Abstract][Full Text] [Related]
49. [Activity of procoagulant and fibrinolysis in homogenate of leukemic cells].
Wada H; Tanigawa M; Suzuki H; Takagi M; Mori Y; Ohno T; Kita K; Kobayashi T; Deguchi K; Shirakawa S
Rinsho Ketsueki; 1989 Oct; 30(10):1783-7. PubMed ID: 2593244
[TBL] [Abstract][Full Text] [Related]
50. Tissue-type plasminogen activator, type 1 plasminogen activator inhibitor and their complex in plasma with disseminated intravascular coagulation.
Fukao H; Ueshima S; Okada K; Yamamoto K; Matsuo T; Matsuo O
Thromb Res; 1992 Oct; 68(1):57-65. PubMed ID: 1280377
[TBL] [Abstract][Full Text] [Related]
51. Disseminated intravascular coagulation in sepsis.
Hardaway RM; Williams CH; Vasquez Y
Semin Thromb Hemost; 2001 Dec; 27(6):577-83. PubMed ID: 11740681
[TBL] [Abstract][Full Text] [Related]
52. [Tissue plasminogen activator (t-PA) and urokinase plasminogen activator (u-PA)].
Kondo S
Nihon Rinsho; 2004 Dec; 62 Suppl 12():700-2. PubMed ID: 15658428
[No Abstract] [Full Text] [Related]
53. Effect of activated protein C on impaired fibrinolysis in rats with obstructive jaundice.
Uchino R; Saitoh N; Hiraoka T; Miyauchi Y
Eur Surg Res; 1992; 24(5):298-301. PubMed ID: 1425827
[TBL] [Abstract][Full Text] [Related]
54. Coagulation abnormalities in malignancy: a review.
Bick RL
Semin Thromb Hemost; 1992; 18(4):353-72. PubMed ID: 1470924
[TBL] [Abstract][Full Text] [Related]
55. [Clinical and experimental studies of septic DIC in surgical patients, in terms of its characteristic features and pathogenesis].
Ono S
Nihon Geka Gakkai Zasshi; 1994 Dec; 95(12):849-59. PubMed ID: 7877583
[TBL] [Abstract][Full Text] [Related]
56. [t-PA x PAI-1 complex].
Maruyama I
Nihon Rinsho; 2004 Dec; 62 Suppl 12():714-6. PubMed ID: 15658432
[No Abstract] [Full Text] [Related]
57. Disseminated intravascular coagulation in hematologic malignancies.
Franchini M; Di Minno MN; Coppola A
Semin Thromb Hemost; 2010 Jun; 36(4):388-403. PubMed ID: 20614391
[TBL] [Abstract][Full Text] [Related]
58. Changes in levels of t-PA and alpha 2PI-plasmin complex in plasma in patients with DIC.
Matsuda T; Asakura H; Ito K; Saito M; Jokaji Y; Uotani C; Kumabashiri I
Thromb Res Suppl; 1988; 8():143-51. PubMed ID: 3144764
[TBL] [Abstract][Full Text] [Related]
59. Phenotypes of Disseminated Intravascular Coagulation.
Wada T; Gando S
Thromb Haemost; 2024 Mar; 124(3):181-191. PubMed ID: 37657485
[TBL] [Abstract][Full Text] [Related]
60. Dysregulation of inflammatory and hemostatic markers in sepsis and suspected disseminated intravascular coagulation.
Hoppensteadt D; Tsuruta K; Hirman J; Kaul I; Osawa Y; Fareed J
Clin Appl Thromb Hemost; 2015 Mar; 21(2):120-7. PubMed ID: 24254894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
